The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayglass, K. T.
Right arrow Articles by Stefura, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayglass, K. T.
Right arrow Articles by Stefura, W. P.

The Journal of Immunology, Vol 147, Issue 8 2455-2460, Copyright © 1991 by American Association of Immunologists


ARTICLES

Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde- modified allergens is paralleled by reciprocal increases in IgG2a synthesis

KT Hayglass and WP Stefura
Department of Immunology, University of Manitoba, Winnipeg, Canada.

Administration of high m.w. glutaraldehyde-polymerized OVA (termed OVA- POL) before OVA-[A1(OH)3] immunization of C57BL/6 mice markedly impairs their capacity to generate OVA-specific IgE responses, while simultaneously resulting in striking enhancement of Ag-specific IgG2a responses. We demonstrate here that treatment with this class of chemically modified allergen also results in pronounced inhibition of ongoing IgE responses in vivo. The abrogation of well established murine IgE responses that is elicited after treatment with OVA-POL (i) is potent (97%), (ii) is long lived, and (iii) reflects reciprocal regulation of Ag-specific IgE and IgG2a responses in vivo. Moreover, the capacity of OVA-POL-treated mice to generate secondary IgE responses remains strongly decreased for at least 260 days and six subsequent immunizations with native allergen, despite there being no further treatment with modified allergen. These changes in IgE and IgG2a responsiveness are Ag specific and T cell dependent.


This article has been cited by other articles:


Home page
J. Immunol.Home page
I. P. Lewkowich, J. D. Rempel, and K. T. HayGlass
Prevention of Allergen-Specific, Th2-Biased Immune Responses In Vivo: Role of Increased IL-12 and IL-18 Responsiveness
J. Immunol., October 15, 2005; 175(8): 4956 - 4962.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kahlert, E. Grage-Griebenow, H.-T. Stuwe, O. Cromwell, and H. Fiebig
T Cell Reactivity with Allergoids: Influence of the Type of APC
J. Immunol., August 15, 2000; 165(4): 1807 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Ahlborg, I. T. Ling, A. A. Holder, and E. M. Riley
Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119
Infect. Immun., April 1, 2000; 68(4): 2102 - 2109.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Brewer, L. Tetley, J. Richmond, F. Y. Liew, and J. Alexander
Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen
J. Immunol., October 15, 1998; 161(8): 4000 - 4007.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. W.P. Seymour, L. J. Gershwin, and R. L. Coffman
Aerosol-induced Immunoglobulin (Ig)-E Unresponsiveness to Ovalbumin Does Not Require CD8+ or T Cell Receptor (TCR)-gamma /delta + T Cells or Interferon (IFN)-gamma in a Murine Model of Allergen Sensitization
J. Exp. Med., March 2, 1998; 187(5): 721 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.